Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 148

1.

Neuroprotective Dipeptide Noopept Prevents DNA Damage in Mice with Modeled Prediabetes.

Ostrovskaya RU, Yagubova SS, Zhanataev AK, Anisina EA, Gudasheva TA, Durnev AD.

Bull Exp Biol Med. 2019 Nov 27. doi: 10.1007/s10517-019-04681-z. [Epub ahead of print]

PMID:
31776952
2.

A New Component in the Mechanism of Regulation of Endogenous Depressive-Like States.

Garibova TL, Gudasheva TA, Seredenin SB.

Dokl Biochem Biophys. 2019 Sep;488(1):324-326. doi: 10.1134/S1607672919050107. Epub 2019 Nov 25.

PMID:
31768852
3.

A Nerve Growth Factor Dipeptide Mimetic Stimulates Neurogenesis and Synaptogenesis in the Hippocampus and Striatum of Adult Rats with Focal Cerebral Ischemia.

Gudasheva TA, Povarnina PY, Volkova AA, Kruglov SV, Antipova TA, Seredenin SB.

Acta Naturae. 2019 Jul-Sep;11(3):31-37. doi: 10.32607/20758251-2019-11-3-31-37.

4.

Anti-Ischemic Activity of Triamine ALM-802 under Conditions of Endothelial Dysfunction.

Barchukov VV, Tsorin IB, Likhosherstov AM, Vititnova MB, Mokrov GV, Gudasheva TA, Kryzhanovskii SA.

Bull Exp Biol Med. 2019 Aug;167(4):460-463. doi: 10.1007/s10517-019-04549-2. Epub 2019 Sep 6.

PMID:
31493255
5.

Dipeptide Mimetic of the BDNF Loop 4 Possesses Analgetic Activity.

Gudasheva TA, Konstantinopolsky MA, Tarasiuk AV, Kolik LG, Seredenin SB.

Dokl Biochem Biophys. 2019 Mar;485(1):123-125. doi: 10.1134/S1607672919020121. Epub 2019 Jun 14.

PMID:
31201630
6.

Effect of Endogenous Neuropeptide Cycloprolylglycine on GABAA Receptors in Cerebellar Purkinje Cells.

Sharonova IN, Bukanova YV, Gudasheva TA, Skrebitsky VG.

Bull Exp Biol Med. 2019 May;167(1):39-42. doi: 10.1007/s10517-019-04455-7. Epub 2019 Jun 8.

PMID:
31177457
7.
8.

A Novel Dipeptide Ligand of TSPO.

Deeva OA, Pantileev AS, Rybina IV, Yarkova MA, Gudasheva TA, Seredenin SB.

Dokl Biochem Biophys. 2019 May;484(1):17-20. doi: 10.1134/S1607672919010046. Epub 2019 Apr 22.

PMID:
31012004
9.

The Low Molecular Weight Brain-derived Neurotrophic Factor Mimetics with Antidepressant-like Activity.

Gudasheva TA, Povarnina P, Tarasiuk AV, Seredenin SB.

Curr Pharm Des. 2019;25(6):729-737. doi: 10.2174/1381612825666190329122852.

PMID:
30931847
10.

Drug with Neuroprotective Properties Noopept Does Not Stimulate Cell Proliferation.

Zainullina LF, Ivanova TV, Ostrovskaya RU, Gudasheva TA, Vakhitova YV, Seredenin SB.

Bull Exp Biol Med. 2019 Feb;166(4):466-468. doi: 10.1007/s10517-019-04373-8. Epub 2019 Feb 20.

PMID:
30788746
11.

Design, Synthesis and Anxiolytic Activity Evaluation of N-Acyltryptophanyl- Containing Dipeptides, Potential TSPO Ligands.

Gudasheva TA, Deeva OA, Mokrov GV, Dyabina AS, Yarkova MA, Seredenin SB.

Med Chem. 2019;15(4):383-399. doi: 10.2174/1573406415666181119164846.

PMID:
30457052
12.

Antidepressant Effect of an Orally Administered Dipeptide Mimetic of the Brain-Derived Neurotrophic Factor.

Povarnina PY, Garibova TL, Gudasheva TA, Seredenin SB.

Acta Naturae. 2018 Jul-Sep;10(3):81-84.

13.

Novel Technologies for Dipeptide Drugs Design and their Implantation.

Gudasheva TA, Ostrovskaya RU, Seredenin SB.

Curr Pharm Des. 2018;24(26):3020-3027. doi: 10.2174/1381612824666181008105641. Review.

14.

Dipeptide Mimetic of the BDNF GSB-106 with Antidepressant-Like Activity Stimulates Synaptogenesis.

Gudasheva TA, Povarnina PY, Antipova TA, Seredenin SB.

Dokl Biochem Biophys. 2018 Jul;481(1):225-227. doi: 10.1134/S1607672918040130. Epub 2018 Aug 31.

PMID:
30168066
15.

[An experimental evaluation of the therapeutic window of the neuroprotective activity of a low-molecular nerve growth factor mimetic GK-2].

Seredenin SB, Povarnina PY, Gudasheva TA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(7):49-53. doi: 10.17116/jnevro20181187149. Russian.

PMID:
30132457
16.

The delayed protective effect of GK-2, а dipeptide mimetic of Nerve Growth Factor, in a model of rat traumatic brain injury.

Genrikhs EE, Voronkov DN, Kapkaeva MR, Gudasheva TA, Glibka YA, Isaev NK, Stelmashook EV.

Brain Res Bull. 2018 Jun;140:148-153. doi: 10.1016/j.brainresbull.2018.05.002. Epub 2018 May 3.

PMID:
29730416
17.

Antidiabetic Properties of Low-Molecular-Weight BDNF Mimetics Depend on the Type of Activation of Post-Receptor Signaling Pathways.

Ostrovskaya RU, Yagubova SS, Gudasheva TA, Seredenin SB.

Bull Exp Biol Med. 2018 Apr;164(6):734-737. doi: 10.1007/s10517-018-4069-y. Epub 2018 Apr 16.

PMID:
29658083
18.

Comparison of the Pharmacological Effects of Dimeric Dipeptide Nerve Growth Factor Mimetic GK-2 and Mexidol on the Model of Ischemic Stroke in Rats.

Povarnina PY, Volkova AA, Gudasheva TA, Seredenin SB.

Bull Exp Biol Med. 2017 Dec;164(2):173-176. doi: 10.1007/s10517-017-3951-3. Epub 2017 Nov 27.

PMID:
29181667
19.

A novel dimeric dipeptide mimetic of the BDNF selectively activates the MAPK-Erk signaling pathway.

Gudasheva TA, Tarasiuk AV, Sazonova NM, Povarnina PY, Antipova TA, Seredenin SB.

Dokl Biochem Biophys. 2017 Sep;476(1):291-295. doi: 10.1134/S1607672917050027. Epub 2017 Nov 4.

PMID:
29101742
20.

Low-Molecular-Weight NGF Mimetic Corrects the Cognitive Deficit and Depression-like Behavior in Experimental Diabetes.

Ostrovskaya RU, Yagubova SS, Gudasheva TA, Seredenin SB.

Acta Naturae. 2017 Apr-Jun;9(2):94-102.

Supplemental Content

Loading ...
Support Center